Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The Innovative Medicines Initiative (IMI) has launched its 11th Call for proposals, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future. |
Característiques principals
The Call has the following topics: Topics under the New Drugs for Bad Bugs (ND4BB) programme on antimicrobial resistance: |
Característiques principals
The Expression of Interest will consist of two sections: The administrative section has to be filled primarily by the ‘Coordinator’. Some information shall be filled directly by the participants under guidance of the Coordinator. The different forms need to be completed on-line using the IMI submission tool (SOFIA): https://sofia.imi.europa.eu/Pages/Login.aspx |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00. • Carol Barnwell, cbarnwell@imim.es. Ext.: 1670 • Marta López, mlopez4@imim.es Ext.: 1576 |
Convocatòria (URL)
http://www.imi.europa.eu/content/11th-call-2013-8 |
Informació addicional
On this page you find information necessary to submit an Expression of Interest in response to the IMI 11th Call 2013: http://www.imi.europa.eu/content/stage-1-11 |
Dotació
IMI JU collaborative projects are implemented through a co-financing scheme. The IMI JU grants financial support to the eligible entities (see conditions above), while the other entities (including the EFPIA companies) participate in the project with their own resources. The EU contribution varies from 0,25 to 25 million €, depending on the topic. |
Durada
The indicative duration of the project is between 4 and 7 years. |
Arxius
Arxiu |
---|
Call text |
Rules for Participation |
Rules for Submission |
Evaluation form Stage 1 |